Total Body Mapping is particularly recommended for the following patient groups:
* For the regular follow-up of patients previously diagnosed with skin cancer (e.g., melanoma).
* For the monitoring of patients with dysplastic nevus syndrome (typically having more than 100 moles).
* For the follow-up of patients deemed high-risk by a physician.